Nov 21, 2019
BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
Oct 01, 2019
Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon
Sep 19, 2019
EU Pharmaceutical Regulations & Strategy Course: Registration Strategy Discussion - Will Brexit Alter this? (London, United Kingdom - October 31, 2019 November 1, 2019)
Sep 19, 2019
EU Pharmaceutical Regulations & Strategy Programme: Post-authorisation Strategy Discussion - Will Brexit Alter this? (London, United Kingdom, April 20-21, 2020)
Jun 06, 2019
Regulatory Affairs for Pharmaceutical Support Staff: Overview of EU Regulatory (Regulations, Directives and Guidelines) Procedures - London, United Kingdom - September 23-24, 2019
Jun 03, 2019
Two Day UK Seminar: Pharmaceutical Regulatory Affairs for Support Staff - Gain an Overview of EU Regulatory Procedures (London, United Kingdom - September 23-24, 2019)
May 21, 2019
Two Day Veterinary Pharmaceutical Submissions in the EU Seminar (London, United Kingdom - May 22-23, 2019)
Mar 01, 2019
Hansa Biopharma Announces European Medicines Agency Accepts Marketing Authorization Application for IDEFIRIX(TM) (imlifidase)
Jul 19, 2018
EU Pharmaceutical Regulations & Strategy Seminar (London, United Kingdom - October 30th-31st, 2018)
Apr 26, 2018
ArisGlobal's LifeSphere EV Triage(TM) Automates Triage of E2B (R3) Cases
Nov 10, 2017
Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum(TM) for the Treatment of Schizophrenia
Oct 04, 2017
PharmaMar Submits the Marketing Authorisation Application for Aplidin® in Switzerland